9.77
-0.37
(-3.68%)
At close: January 31 at 9:34:10 PM GMT+1
Key Executives
Key Executives Information Not Available
Intellia Therapeutics Inc
Profile Information Not Available
Description
Description Information Not Available
Corporate Governance
Intellia Therapeutics Inc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
February 20, 2025 at 1:30 PM UTC - February 24, 2025 at 1:30 PM UTC
Intellia Therapeutics Inc Earnings Date
Recent Events
Recent Events Information Not Available
Related Tickers
FYB.MU Formycon AG
54.70
+1.11%
1U5.SG Wave Life Sciences Ltd.
11.10
-3.48%
63E.MU Onward Medical NV
6.34
-6.49%
63E.BE Onward Medical NV
6.38
+0.31%
VVY.AS Vivoryon Therapeutics N.V.
2.0000
-0.50%
FYB.DE Formycon AG
53.60
-0.92%
ONWD.BR Onward Medical N.V.
6.36
+0.95%
BMEA Biomea Fusion, Inc.
4.1800
-1.65%
DNLI Denali Therapeutics Inc.
23.30
-1.19%
TERN Terns Pharmaceuticals, Inc.
4.4600
-3.88%